Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's After-Market Session

Author: Benzinga Insights | May 30, 2025 05:05pm

Gainers

  • Plus Therapeutics (NASDAQ:PSTV) shares rose 32.5% to $0.38 during Friday's after-market session. The market value of their outstanding shares is at $2.2 million. As per the press release, Q1 earnings came out today.
  • Kymera Therapeutics (NASDAQ:KYMR) shares rose 15.99% to $34.38. The market value of their outstanding shares is at $2.2 billion.
  • Liquidia (NASDAQ:LQDA) stock moved upwards by 10.52% to $16.49. The company's market cap stands at $1.4 billion.
  • Ironwood Pharmaceuticals (NASDAQ:IRWD) shares moved upwards by 10.16% to $0.66. The market value of their outstanding shares is at $106.8 million.
  • Rafael Holdings (NYSE:RFL) stock rose 8.38% to $1.55. The market value of their outstanding shares is at $57.7 million.
  • Biote (NASDAQ:BTMD) shares increased by 8.37% to $3.75. The market value of their outstanding shares is at $118.0 million.

Losers

  • LogicMark (NASDAQ:LGMK) stock declined by 29.6% to $0.01 during Friday's after-market session. The market value of their outstanding shares is at $4.6 million.
  • Reshape Lifesciences (NASDAQ:RSLS) stock fell 15.69% to $4.14. The market value of their outstanding shares is at $3.0 million.
  • Entero Therapeutics (NASDAQ:ENTO) shares decreased by 11.63% to $0.38. The market value of their outstanding shares is at $1.8 million.
  • Basel Medical Group (NASDAQ:BMGL) shares fell 10.53% to $5.44. The market value of their outstanding shares is at $102.1 million.
  • Silexion Therapeutics (NASDAQ:SLXN) shares declined by 8.74% to $0.94. The company's market cap stands at $8.1 million.
  • Intensity Therapeutics (NASDAQ:INTS) shares decreased by 8.44% to $0.44. The market value of their outstanding shares is at $8.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BMGL BTMD ENTO INTS IRWD KYMR LGMK LQDA PSTV RFL RSLS SLXN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist